<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="ame270055" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Animal Model Exp Med</journal-id><journal-id journal-id-type="iso-abbrev">Animal Model Exp Med</journal-id><journal-id journal-id-type="pmc-domain-id">3615</journal-id><journal-id journal-id-type="pmc-domain">animalmod</journal-id><journal-id journal-id-type="publisher-id">AME2</journal-id><journal-title-group><journal-title>Animal Models and Experimental Medicine</journal-title></journal-title-group><issn pub-type="ppub">2096-5451</issn><issn pub-type="epub">2576-2095</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12431572</article-id><article-id pub-id-type="pmcid-ver">PMC12431572.1</article-id><article-id pub-id-type="pmcaid">12431572</article-id><article-id pub-id-type="pmcaiid">12431572</article-id><article-id pub-id-type="pmid">40583791</article-id><article-id pub-id-type="doi">10.1002/ame2.70055</article-id><article-id pub-id-type="publisher-id">AME270055</article-id><article-id pub-id-type="other">AMEM-2025-0137.R1</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Themed Section: Mechanism Verification of Plant Bioactive Components</subject><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></subj-group></article-categories><title-group><article-title>Diosgenin ameliorates silica&#8208;induced tuberculosis in rats</article-title><alt-title alt-title-type="left-running-head">Adu et&#160;al.</alt-title></title-group><contrib-group><contrib id="ame270055-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Adu</surname><given-names initials="WA">Williams Asamoah</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0007-6246-7035</contrib-id><xref rid="ame270055-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>williams.adu-asamoah@stu.edu.gh</email></address></contrib><contrib id="ame270055-cr-0002" contrib-type="author"><name name-style="western"><surname>Ativui</surname><given-names initials="S">Selase</given-names></name><xref rid="ame270055-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ame270055-cr-0003" contrib-type="author"><name name-style="western"><surname>Ofori</surname><given-names initials="M">Michael</given-names></name><xref rid="ame270055-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ame270055-cr-0004" contrib-type="author"><name name-style="western"><surname>Owusu</surname><given-names initials="G">George</given-names></name><xref rid="ame270055-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="ame270055-cr-0005" contrib-type="author"><name name-style="western"><surname>Danquah</surname><given-names initials="CA">Cynthia Amaning</given-names></name><xref rid="ame270055-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ame270055-cr-0006" contrib-type="author"><name name-style="western"><surname>Poku Sampene Ossei</surname><given-names initials="P">Paul</given-names></name><xref rid="ame270055-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="ame270055-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Pharmaceutical Sciences, Faculty of Applied Science and Technology</named-content>
<institution>Sunyani Technical University</institution>
<city>Sunyani</city>
<country country="GH">Ghana</country>
</aff><aff id="ame270055-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences</named-content>
<institution>College of Health Sciences, Kwame Nkrumah University of Science and Technology, PMB</institution>
<city>Kumasi</city>
<country country="GH">Ghana</country>
</aff><aff id="ame270055-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Medical Laboratory Science</named-content>
<institution>University of Energy and Natural Resources</institution>
<city>Sunyani</city>
<country country="GH">Ghana</country>
</aff><aff id="ame270055-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Pathology, School of Medicine and Dentistry</named-content>
<institution>Kwame Nkrumah University of Science and Technology</institution>
<city>Kumasi</city>
<country country="GH">Ghana</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Williams Asamoah Adu, Department of Pharmaceutical Sciences, Faculty of Applied Science and Technology, Sunyani Technical University, P.O. Box&#160;206, Sunyani, Ghana.<break/>
Email: <email>williams.adu-asamoah@stu.edu.gh</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>6</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>7</month><year>2025</year></pub-date><volume>8</volume><issue seq="50">7</issue><issue-id pub-id-type="pmc-issue-id">496817</issue-id><issue-id pub-id-type="doi">10.1002/ame2.v8.7</issue-id><issue-title content-type="special-issue-title">Themed Issue: Mechanism Verification of Plant Bioactive Components</issue-title><fpage>1186</fpage><lpage>1195</lpage><history><date date-type="rev-recd"><day>06</day><month>6</month><year>2025</year></date><date date-type="received"><day>16</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>14</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>30</day><month>06</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 The Author(s). <italic toggle="yes">Animal Models and Experimental Medicine</italic> published by John Wiley &amp; Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="AME2-8-1186.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:AME2-8-1186.pdf"/><abstract><title>Abstract</title><sec id="ame270055-sec-0001"><title>Background</title><p>Silicosis is an occupational lung disease that is caused by chronic exposure to silica dust. Silica&#8208;exposed workers are at higher risk of developing TB, resulting in lung fibrosis and significant respiratory dysfunction. Diosgenin is a steroidal saponin that has been shown to exert a therapeutic effect on lung injury. Therefore, we investigated the potential efficacy of diosgenin in treating silicotuberculosis by evaluating its effectiveness against <italic toggle="no">Mycobacterium smegmatis</italic>, as well as its antifibrotic and antioxidant effects in silica&#8208;induced TB in rats.</p></sec><sec id="ame270055-sec-0002"><title>Methods</title><p>Silicosis was induced by intratracheal instillation of 50&#8201;mg/kg crystalline silica in Sprague&#8211;Dawley rats. Rats were grouped into 7 (10 per group). Different doses of diosgenin (1, 10, and 20&#8201;mg/kg) and saline were administered for 30&#8201;days. Afterwards, five rats from each group were sacrificed, and the five remaining rats in each group, except the control, received <italic toggle="no">Mycobacterium smegmatis</italic>. Treatment continued until the 50th day, and the animals were sacrificed at the end of the experiment. The result was analyzed using a one&#8208;way analysis of variance (ANOVA) with GraphPad Prism.</p></sec><sec id="ame270055-sec-0003"><title>Results</title><p>At a half&#8208;maximal inhibition concentration of 0.006043&#8201;&#956;g/mL, diosgenin inhibited the growth of <italic toggle="no">Mycobacterium smegmatis</italic>. Oxidative stress markers such as malondialdehyde were significantly reduced. The health&#8208;enhancing effects of catalase and superoxide dismutase were elevated. Additionally, histological findings demonstrated a significant improvement in respiratory function following diosgenin treatment.</p></sec><sec id="ame270055-sec-0004"><title>Conclusion</title><p>Diosgenin treatment inhibited the growth of <italic toggle="no">Mycobacterium smegmatis,</italic> leading to a reduction in the susceptibility of rats to infection and improved pulmonary function through its antioxidant effect.</p></sec></abstract><abstract abstract-type="graphical"><p>Silicosis increases susceptibility to tuberculosis due to impaired macrophage function and oxidative stress. This study demonstrates that diosgenin, a steroidal saponin, significantly inhibits <italic toggle="no">Mycobacterium smegmatis</italic> (IC&#8325;&#8320;&#8201;=&#8201;0.006&#8201;&#956;g/mL), reduces lung fibrosis, and restores antioxidant enzyme levels (&#8593;SOD, &#8593;CAT, &#8595;MDA) in silica&#8208;exposed rats. Histological analysis revealed improved alveolar architecture and reduced inflammation following 30&#8211;50&#8201;days of treatment. These findings suggest that diosgenin is a promising dual&#8208;action compound for managing silicotuberculosis through antimicrobial, antioxidant, and antifibrotic mechanisms.<boxed-text position="anchor" content-type="graphic" id="ame270055-blkfxd-0001" orientation="portrait"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="AME2-8-1186-g007.jpg"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="ame270055-kwd-0001">antioxidant</kwd><kwd id="ame270055-kwd-0002">diosgenin</kwd><kwd id="ame270055-kwd-0003">mycobacterium</kwd><kwd id="ame270055-kwd-0004">pulmonary fibrosis</kwd><kwd id="ame270055-kwd-0005">silicosis</kwd><kwd id="ame270055-kwd-0006">silicotuberculosis</kwd></kwd-group><counts><fig-count count="8"/><table-count count="1"/><page-count count="10"/><word-count count="7000"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>July 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.2 mode:remove_FC converted:12.09.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="AME270055-cit-2001"><string-name name-style="western"><surname>Adu</surname><given-names>WA</given-names></string-name>, <string-name name-style="western"><surname>Ativui</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ofori</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Owusu</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Danquah</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Poku Sampene Ossei</surname><given-names>P</given-names></string-name>. <article-title>Diosgenin ameliorates silica&#8208;induced tuberculosis in rats</article-title>. <source>Anim Models Exp Med</source>. <year>2025</year>;<volume>8</volume>:<fpage>1186</fpage>&#8208;<lpage>1195</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ame2.70055</pub-id><pub-id pub-id-type="pmcid">PMC12431572</pub-id><pub-id pub-id-type="pmid">40583791</pub-id></mixed-citation>
</p></notes></front><body id="ame270055-body-0001"><sec id="ame270055-sec-0005"><label>1</label><title>INTRODUCTION</title><p>Silicosis is a work&#8208;related interstitial lung disease caused by the long&#8208;term inhalation of crystalline silica dust.<xref rid="ame270055-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> The prevalence and incidence of this disease have been rising in developing countries such as China, South Africa, Brazil and among underground miners in Ghana.<xref rid="ame270055-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> It is estimated that 10 million workers are exposed to crystalline silica worldwide.<xref rid="ame270055-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> Workers exposed to silica face a threefold or greater risk of developing mycobacterium infection, resulting in a complication known as silicotuberculosis.<xref rid="ame270055-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> Thus, there is a close association between silicosis and tuberculosis.<xref rid="ame270055-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>
</p><p>The anatomy of the respiratory tract exposes the lungs to the toxic effects of dust particles.<xref rid="ame270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> Silica can withstand enzymatic breakdown. The inhaled particle is engulfed by an alveolar macrophage, which serves as the first line of defense. Moreover, silica dust resists digestion by the lysosome. Also, the particle size is too small to evade mucociliary clearance in the lungs. Silica irritates the mitochondrial membrane, resulting in increased levels of reactive oxygen species. The mitochondrial membrane potential is eventually impaired, reducing ATP production.<xref rid="ame270055-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Proinflammatory cytokine levels are elevated to stimulate a profibrotic response, leading to collagen deposition.<xref rid="ame270055-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> The lung is characterized by nodular lesion formation, epithelial&#8208;mesenchymal transition, fibroblast activation to myofibroblast, collagen hyperplasia, and fibrosis formation.<xref rid="ame270055-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> The imbalance between enzymes and levels of free radicals determines the degree of damage. The situation is further worsened by mycobacterium infection.<xref rid="ame270055-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> Once the alveolar macrophage defense is compromised, latent tubercle bacilli are activated, leading to the initiation and progression of TB.</p><p>
<italic toggle="yes">Mycobacterium tuberculosi</italic>s can thrive within the host's primary immune cells for an extended period under various stress conditions. In addition to its complex structure, <italic toggle="yes">Mycobacterium tuberculosis</italic> is a slow&#8208;growing and highly infectious bacterium. This poses a significant setback in the drug screening procedures for inhibiting mycobacterial growth. It has been reported that <italic toggle="yes">M. smegmatis</italic> is over 90 per cent identical to <italic toggle="yes">M. tuberculosis</italic> and shares a common gene involved in stress adaptation.<xref rid="ame270055-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> A <italic toggle="yes">M. smegmatis</italic> strain (ATCC 607) has been reported to show drug susceptibility similar to that of the <italic toggle="yes">Mycobacterium tuberculosis</italic> H37Rv strain. To avoid the use of highly infectious <italic toggle="yes">M. tuberculosis</italic>, which requires a higher level of safety, <italic toggle="yes">Mycobacterium smegmatis</italic> was used as a surrogate model to study the pattern of the disease.<xref rid="ame270055-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="ame270055-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>
</p><p>Silicosis is a potentially fatal disease that severely impacts lung function and survival.<xref rid="ame270055-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> Tuberculosis significantly contributes to morbidity and mortality in patients. Currently, there is no effective therapy to reverse silicosis and its associated pulmonary complications. Lung function continues to deteriorate even when the disease progression is reduced and after the patient is no longer exposed. The median survival rate ranges from 3 to 5&#8201;years.<xref rid="ame270055-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> The condition is exacerbated by the undesirable effects of drugs used for treatment.<xref rid="ame270055-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Lung transplantation remains the only remedy for patients who are refractory to conventional therapy. Currently, pirfenidone and nintedanib are the only approved antifibrotic medications available for clinical use; however, there are limited findings regarding their ability to reduce mycobacterial susceptibility.<xref rid="ame270055-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>
</p><p>Previous research on diosgenin has demonstrated its anti&#8208;inflammatory, anti&#8208;proliferative, and antioxidant properties.<xref rid="ame270055-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Studies have shown its ability to treat respiratory diseases, as well as liver and cardiac fibrosis. However, the ability of the compound to protect lung tissue from oxidative stress in silica&#8208;induced fibrosis and associated silicosis, or silicotuberculosis, has not received sufficient research attention. This research aims to investigate the efficacy of diosgenin in reducing the susceptibility of rats to <italic toggle="yes">Mycobacterium smegmatis</italic> infection, as well as its antioxidant activity and histological findings after silica&#8208;induced pulmonary fibrosis.</p></sec><sec sec-type="materials-and-methods" id="ame270055-sec-0006"><label>2</label><title>MATERIALS AND METHODS</title><sec id="ame270055-sec-0007"><label>2.1</label><title>In vitro determination of minimum inhibitory concentration (<styled-content style="fixed-case" toggle="no">MIC</styled-content>) of diosgenin</title><p>The drug susceptibility of <italic toggle="yes">Mycobacterium smegmatis</italic> was investigated using the high&#8208;throughput spot culture growth inhibition assay (HT&#8208;SPOTi) technique.<xref rid="ame270055-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> The aim was to determine the amount of diosgenin required to inhibit the growth of <italic toggle="yes">Mycobacterium smegmatis</italic>. Middle&#8208;brook 7H10 (MB7H10) agar with 0.5% glycerol was autoclaved. Oleic albumin dextrose and catalase (OADC 10% v/v) were added as a supplement. The agar was placed in a water bath at 55&#176; to 60&#176;C to prevent solidification. <italic toggle="yes">Mycobacterium smegmatis mc</italic>
<sup>2</sup> 155, (ATCC 19420) was inoculated in 10&#8201;mL of MB 7H10 and incubated at 37&#176;C for 20&#8211;24&#8201;h. Microbial growth on the agar was washed with 0.9% (w/v) normal saline solution. A 100&#8201;&#956;L aliquot of the washed bacteria was dispensed into a Falcon tube containing 10&#8201;mL sterile normal saline. A 1&#8201;mL aliquot of the bacterial suspension from the previous tube was transferred into a new Falcon tube containing 9&#8201;mL of normal saline. Another 1&#8201;mL aliquot of the suspension was further transferred into the last Falcon tube containing 19&#8201;mL of normal saline to mark the end of the serial dilution. Drugs/inhibitors (diosgenin, rifampicin, and isoniazid) were weighed and dissolved in 1&#8201;mL of 0.3% dimethyl sulfoxide (DMSO) to achieve a stock concentration of 50&#8201;mg/mL. Two&#8208;fold serial dilution of the stock solution was carried out in a half&#8208;skirted 96&#8208;well PCR plate as previously reported.<xref rid="ame270055-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>
</p></sec><sec id="ame270055-sec-0008"><label>2.2</label><title>Care of animals</title><p>Sprague&#8211;Dawley (SD) rats were obtained from the Noguchi Memorial Institute for Medical Research, University of Ghana, Legon. They were housed in the animal house of the Department of Pharmacology at KNUST, Kumasi. The rats were housed in stainless steel cages with soft wood shavings as bedding, fed with a pellet diet (GAFCO, Tema) and water was given ad&#160;libitum. The room was maintained at a temperature of 24&#8211;28&#176;C and relative humidity of 60&#8211;70%, under a 12&#8208;h light&#8211;dark cycle. All procedures and techniques used in this study were in accordance with the <italic toggle="yes">National Institute of Health Guidelines for the Care and Use of Laboratory Animals</italic> (8th edition, 2011). Ethical approval (FPPS/008/2018) was obtained from the Department of Pharmacology, Animal Ethics Committee, KNUST, Kumasi, Ghana.</p></sec><sec id="ame270055-sec-0009"><label>2.3</label><title>Experimental design</title><p>After 7&#8201;days of acclimatization, 8&#8208;week&#8208;old SD rats (120&#8211;200&#8201;g) were randomized into seven groups without exclusion criteria. Ten experimental units of rats were allocated to each group. The experiment was conducted in two stages. Five rats from each group were randomly selected and sacrificed on day 30 to assess silicosis. The remaining five rats in each group received mycobacteria on day 31. Silicosis induction occurred on day 1. Both the silicosis group and the silica plus mycobacterium group, but not the na&#239;ve group, were administered diosgenin treatment from day 1 to day 50. Prednisolone and rifampicin were used as standard drugs for treatment of silicosis and mycobacterium, respectively. The entire experiment lasted for 50&#8201;days.</p><p>Rats were grouped and treated as follows:
<list list-type="simple" id="ame270055-list-0001"><list-item id="ame270055-li-0001"><p>Group 1 (Naive) received normal saline 1&#8201;mg/kg intratracheally on day 1.</p></list-item><list-item id="ame270055-li-0002"><p>Group 2 (Silica + Myco) received (50&#8201;mg/kg) crystalline silica&#8208;only plus 500&#8201;&#215;&#8201;10<sup>7</sup>&#8201;CFU of <italic toggle="yes">Mycobacterium smegmatis</italic> intratracheally on day 1.</p></list-item><list-item id="ame270055-li-0003"><p>Group 3 (Dios 1) received crystalline silica on day 1 and diosgenin (1&#8201;mg/kg&#8201;i.p.) from day 1 to day 50.</p></list-item><list-item id="ame270055-li-0004"><p>Group 4 (Dios 10) received crystalline silica on day 1 and diosgenin (10&#8201;mg/kg&#8201;i.p.) from day 1 to day 50.</p></list-item><list-item id="ame270055-li-0005"><p>Group 5 (Dios 20) received crystalline silica on day 1 and diosgenin (20&#8201;mg/kg&#8201;i.p.) from the first day 1 to day 50.</p></list-item><list-item id="ame270055-li-0006"><p>Group 6 (Pred) received silica on day 1 and prednisolone (10&#8201;mg/kg&#8201;i.p.) from day 1 to 30.</p></list-item><list-item id="ame270055-li-0007"><p>Group 7 (Rif) received silica on day 1 and rifampicin (10&#8201;mg/kg&#8201;i.p.) from day 30 to 50.</p></list-item></list>
</p><p>Rats were anesthetized with pentobarbitone (40&#8201;mg/kg) and 50&#8201;mg/kg of crystalline silica was induced intratracheally (50&#8201;mg in 100&#8201;&#956;L of normal saline for each rat). After silica instillation, the rats were turned upside down immediately to ensure an even distribution of silica in the lungs.<xref rid="ame270055-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="ame270055-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>
</p></sec><sec id="ame270055-sec-0010"><label>2.4</label><title>Sample collection</title><p>On the 30th day following silica induction, the rats were anesthetized with pentobarbitone (40&#8201;mg/kg). The chest was gently opened wide, and then both lungs were taken and fixed in 10% formalin for 24&#8201;h until the tissue became hard enough for sectioning.</p></sec><sec id="ame270055-sec-0011"><label>2.5</label><title>Determination of body weight and lung index</title><p>This assay measures the weight of the wet lung in milligrams in relation to the weight of the rat in grams. The pulmonary index is used to indicate the ventilatory status and, thus, the level of pulmonary edema. The rats were weighed before and after the experiment. The weight gain in each category was recorded. After ablation, the extracted lungs were trimmed of foreign tissue, cleaned, and weighed. The pulmonary index was calculated as the proportion of lung weight (mg) to body weight (g) of each animal.</p></sec><sec id="ame270055-sec-0012"><label>2.6</label><title>Clinical assessment of silicosis with H&amp;E stain</title><p>Rats were assessed for inflammation before infection with mycobacterium. The lungs were dehydrated, embedded in paraffin, and sectioned into 4&#8208;&#956;m&#8208;thick slices. The tissue was then stained with Hematoxylin for 5&#8201;min, followed by Eosin (H&amp;E) stain. The slides were viewed under a light microscope (United Medical Laboratories, Riyadh, Saudi Arabia) at a magnification of &#215;10.<xref rid="ame270055-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>
</p></sec><sec id="ame270055-sec-0013"><label>2.7</label><title>Biochemical analysis</title><p>A 4.5&#8201;mL tissue homogenizing buffer (pH&#8201;7.4) was added to each lung specimen on ice. A tissue homogenizer was used to blend the lung tissues into intracellular components for 15&#8201;min. The homogenate was centrifuged at 4000&#8201;&#215;&#8201;g for 20&#8201;min, decanted, and assayed.</p></sec><sec id="ame270055-sec-0015"><label>2.8</label><title>Growth of mycobacterium culture</title><p>MB7H9 broth (0.15&#8201;g), glycerol (66&#8201;&#956;L) and 0.1% Tween 80 (83&#8201;&#956;L) were added to a conical flask, and mixed thoroughly. The solution was autoclaved at 121&#176;C for 10&#8201;min and allowed to cool. A 9&#8201;mL aliquot of broth was taken into a conical flask, followed by 1&#8201;mL of OADC. A 0.1&#8201;mL aliquot of the organism was then added and incubated at 37&#176;C for 24&#8201;h.<xref rid="ame270055-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>
</p></sec><sec id="ame270055-sec-0016"><label>2.9</label><title>Induction of tuberculosis</title><p>For the five remaining rats in each group, each rat was injected intranasally with 500&#8201;&#215;&#8201;10<sup>7</sup>&#8201;CFU/mL of <italic toggle="yes">Mycobacterium smegmatis</italic>. Treatment with diosgenin continued until day 50. On the 20th day post&#8208;infection, the rats were anesthetized by intraperitoneal injection of pentobarbital sodium (40&#8201;mg/kg), sacrificed instantly, and the lungs excised. The lung tissues were subjected to Van Gieson stain to differentiate between collagen fibers and smooth muscle.</p><p>Lung tissues were fixed in 10% formalin for 36&#8201;h, dehydrated and embedded in paraffin. The tissues were sectioned into 4&#8201;&#956;m&#8208;thick slices. The sections were stained with Van Gieson stain to assess collagen deposition. The slides were viewed under a light microscope (United Medical Laboratories, Riyadh, Saudi Arabia) at a magnification of &#215;20.</p></sec><sec id="ame270055-sec-0018"><label>2.10</label><title>
<italic toggle="no">M. smegmatis</italic> colony&#8208;forming unit count</title><p>To 3.8&#8201;g of MB7H10 agar powder, 180&#8201;mL of distilled water was added and autoclaved. Sterilized Eppendorf tubes were labeled 1 to 9. A 900&#8201;&#956;L of saline was transferred into the tubes. Lung tissues were homogenized in tissue homogenizing buffer, centrifuged and decanted to obtain a bacterial suspension. A 10&#8201;mL aliquot of bacterial sample was prepared and vortexed to ensure even distribution. A 100&#8201;&#956;L aliquot of the bacteria suspension was aseptically transferred into the labeled tubes. Serial dilution of the bacteria was performed. Each of the Petri dishes was labeled accordingly. A 100&#8201;&#956;L of each of the serial dilutions was transferred to the centre of each agar plate and streaked with a spreader. The plate was closed, inverted, and incubated at 37&#176;C.<xref rid="ame270055-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> CFU was calculated as:<disp-formula id="ame270055-disp-0003"><mml:math id="jats-math-1" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:mtext>CFU</mml:mtext><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>Number of colonies</mml:mtext><mml:mo>&#215;</mml:mo><mml:mtext>dilution factor</mml:mtext></mml:mrow><mml:mtext>Amount plated</mml:mtext></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
</p></sec><sec id="ame270055-sec-0019"><label>2.11</label><title>Evaluation of in&#160;vivo antioxidant activity of diosgenin</title><sec id="ame270055-sec-0020"><label>2.11.1</label><title>Superoxide dismutase (<styled-content style="fixed-case" toggle="no">SOD</styled-content>) activity</title><p>This assay is based on the utilization of the superoxide anion formed as a result of the autoxidation reaction of adrenaline in an alkaline medium. Adrenochrome from adrenaline autoxidation is prevented by SOD.<xref rid="ame270055-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> A 500&#8201;&#956;L of homogenized lung tissue was centrifuged in 150&#8201;&#956;L of very cold chloroform and 750&#8201;&#956;L ethanol (96% v/v) at 2000&#8201;g for 20&#8201;min. Consecutive increments of 1&#8201;mL carbonate buffer (0.1&#8201;M, pH&#8201;10.2) and 0.5&#8201;mL EDTA (0.6&#8201;mM) were added to 500&#8201;&#956;L of supernatant aliquot. A 0.05&#8201;mL of (1.3&#8201;mM) adrenaline was then added to generate adrenochrome. A blank was prepared, which excluded the tissue homogenate. A 150&#8201;&#956;L of the resultant was pipetted onto the microplate. The values for absorbance were measured at 480&#8201;nm by a Synergy H1 Multi&#8208;Mode Reader (BioTek Innovations, Winooski, USA). The percentage hindrance of adrenaline autoxidation was determined as:<disp-formula id="ame270055-disp-0001"><mml:math id="jats-math-2" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtext>Inhibition</mml:mtext><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:msub><mml:mtext>Absorbance</mml:mtext><mml:mtext>test</mml:mtext></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mtext>Absorbance</mml:mtext><mml:mtext>blank</mml:mtext></mml:msub></mml:mrow><mml:msub><mml:mtext>Absorbance</mml:mtext><mml:mtext>test</mml:mtext></mml:msub></mml:mfrac></mml:mfenced><mml:mo linebreak="goodbreak">&#215;</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula>
</p><p>Superoxide dismutase action was measured in units per mg protein, where a unit is the amount of the enzyme that inhibited 50% autoxidation of adrenaline at 25&#176;C; determined from the equation:</p><p>Units of SOD activity/mg protein&#8201;=&#8201;(% inhibition)/(50&#8201;&#215;&#8201;weight of protein).</p></sec><sec id="ame270055-sec-0021"><label>2.11.2</label><title>Catalase (<styled-content style="fixed-case" toggle="no">CAT</styled-content>) activity</title><p>This assay is based on the reduction of dichromate in acetic acid to chromic acid when heated in the presence of hydrogen peroxide. The chromic acetate produced is then measured calorimetrically.<xref rid="ame270055-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> The assay mixture, containing 0.4&#8201;mL of H<sub>2</sub>O<sub>2</sub> (1.18&#8201;M) and 1&#8201;mL of phosphate buffer (0.01&#8201;M, pH&#8201;7.0), was added to 0.1&#8201;mL of tissue homogenate and incubated for 5&#8201;min at room temperature. A volume of 2&#8201;mL of dichromate&#8208;acetic acid (containing three parts of glacial acetic acid and 1 part of 5% potassium dichromate) was added to end the response. A 150&#8201;&#956;L aliquot of the resultant mixture was transferred into a 96&#8208;well microplate. The absorbance was measured using spectrophotometry at a wavelength of 620&#8201;nm. CAT activity was calculated based on the extinction coefficient of H<sub>2</sub>O<sub>2</sub>, 39.4/M/cm at 620&#8201;nm, and expressed as a unit per milligram protein. One unit of the CAT enzyme is expected to hydrolyze 1&#8201;mmol of H<sub>2</sub>O<sub>2</sub> per min, at pH&#8201;=&#8201;7 and 25&#176;C.<disp-formula id="ame270055-disp-0002"><mml:math id="jats-math-3" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtext>Unit of</mml:mtext><mml:mspace width="0.25em"/><mml:mfenced close=")" open="("><mml:mrow><mml:mi>CAT</mml:mi><mml:mspace width="0.25em"/><mml:mtext>activity</mml:mtext><mml:mo>/</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mi>mg</mml:mi><mml:mspace width="0.25em"/><mml:mtext>protein</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mrow><mml:mtext>Absorbance</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:mn>620</mml:mn><mml:mspace width="0.25em"/><mml:mi>nm</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mfenced close=")" open="("><mml:mrow><mml:mn>39.4</mml:mn><mml:mo linebreak="goodbreak">&#215;</mml:mo><mml:mtext>weight of protein</mml:mtext></mml:mrow></mml:mfenced></mml:mfrac><mml:mo linebreak="goodbreak">&#215;</mml:mo><mml:mn>1000</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula>
</p></sec><sec id="ame270055-sec-0022"><label>2.11.3</label><title>Lipid peroxidation assay</title><p>Lipids have unique structural and functional roles in cell membranes. Disturbing this role through covalent binding and oxidation can lead to cell death. The extent of damage is determined by how much malondialdehyde (MDA) is produced. This assay illustrates the extent of oxygen&#8208;driven damage in the thiobarbituric acid (TBA) assay, as indicated by the color change. The quantity of MDA was measured as previously described by Heath and Parker.<xref rid="ame270055-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> To 1&#8201;mL of tissue homogenate, 3&#8201;mL of a mixture of 20% TCA in 0.5% TBA was added. The mixture was warmed at 95&#176;C for half an hour, and allowed to cool. The sample was then centrifuged at 5000&#8201;&#215;&#8201;g for 10&#8201;min. Absorbance was measured at 532&#8201;nm and then at 600&#8201;nm to correct for nonspecific absorbance. The molar extinction coefficient of the MDA&#8208;TBA product, 155/mM/cm was used to quantify the amount of MDA formed.</p></sec></sec><sec id="ame270055-sec-0023"><label>2.12</label><title>Statistical analysis</title><p>GraphPad Prism version 8 was used for all statistical analyses. Data with two independent variables were analyzed using two&#8208;way ANOVA followed by Dunnett's post hoc test, whereas those with a single independent variable were analyzed using one&#8208;way ANOVA. Results were presented as mean&#8201;&#177;&#8201;SEM. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="ame270055-sec-0024"><label>3</label><title>RESULTS</title><sec id="ame270055-sec-0025"><label>3.1</label><title>In vitro determination of the minimum inhibitory concentration of diosgenin</title><p>The half&#8208;maximal inhibitory concentration (IC50) of diosgenin was determined to be 0.006043&#8201;&#956;g/mL, with a correlation coefficient of 0.86 (Table&#160;<xref rid="ame270055-tbl-0001" ref-type="table">1</xref>).</p><table-wrap position="float" id="ame270055-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Half&#8208;maximal inhibitory concentration (IC<sub>50</sub>) of diosgenin, isoniazid and rifampicin against <italic toggle="no">Mycobacterium smegmatis</italic>.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Drug</th><th align="left" valign="bottom" rowspan="1" colspan="1">IC<sub>50</sub> (&#956;g/mL)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Diosgenin</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.006043</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Isoniazid</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1192</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rifampicin</td><td align="char" char="." valign="top" rowspan="1" colspan="1">52.55</td></tr></tbody></table></table-wrap></sec><sec id="ame270055-sec-0026"><label>3.2</label><title>Body weight changes</title><p>There was a significant improvement in the body weight of rats treated with diosgenin compared to the silica&#8208;only group. The&#160;silicosis group weighed an average of 128&#8201;g before the experiment and 128.7&#8201;g at the end of the experiment. In the silica plus mycobacterium group, the 1&#8201;mg/kg diosgenin&#8208;treated group weighed 155.1&#8201;g at the beginning and 162&#8201;g at the end of the experiment. The 10&#8201;mg/kg diosgenin weighed 150.4&#8201;g before and 159&#8201;g at the termination of the experiment. The 20&#8201;m/kg group weighed 190.3&#8201;g and 198&#8201;g before and after the experiment, respectively. Treatment with diosgenin at all doses (1, 10, and 20&#8201;mg/kg) resulted in significant weight gain, suggesting an improvement in overall metabolic status and immune function.</p></sec><sec id="ame270055-sec-0027"><label>3.3</label><title>Lung index</title><p>The lung weight of rats after the silica challenge increased to a mean value of 0.8260&#8201;&#177;&#8201;0.02084&#8201;mg/g (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001) compared to the naive control rats. Diosgenin administration reduced the mean weight to 0.2133&#8201;&#177;&#8201;0.02084&#8201;mg/g (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.01), 0.4967&#8201;&#177;&#8201;0.02084 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.001), 0.6700&#8201;&#177;&#8201;0.02084&#8201;mg/g (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001) at doses of 1, 10 and 20&#8201;mg/kg, respectively, with an <italic toggle="yes">F</italic> value of 474.3&#8201;mg/g. After introduction of silica followed by <italic toggle="yes">Mycobacterium</italic>, the mean difference rose to 0.9440&#8201;&#177;&#8201;0.03504&#8201;mg/g (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001) compared to the naive control rats. Rifampicin significantly (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.05) reduced the lung weight to a mean of 0.8100&#8201;&#177;&#8201;0.03504&#8201;mg/g (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001). Diosgenin administration reduced the total lung weight (mg/g) to 0.3100&#8201;&#177;&#8201;0.03504 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.01), 0.4800&#8201;&#177;&#8201;0.03504 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.001), 0.5265&#8201;&#177;&#8201;0.03504&#8201;mg/g (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.001) at doses of 1, 10 and 20&#8201;mg/kg, respectively, with an <italic toggle="yes">F</italic> value of 188.8 (Figure&#160;<xref rid="ame270055-fig-0001" ref-type="fig">1</xref>). In a previous study, inflammation was found to lead to skeletal muscle wasting and weight loss.<xref rid="ame270055-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>
</p><fig position="float" fig-type="FIGURE" id="ame270055-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Effect of diosgenin on the pulmonary index. Diosgenin reduced lung weights in both the silicosis and the silica plus <italic toggle="yes">Mycobacterium</italic> groups. Data are expressed as mean&#8201;&#177;&#8201;SEM. <italic toggle="yes">n</italic>&#8201;=&#8201;10, one&#8208;way ANOVA and Dunnett's post hoc test. <italic toggle="yes">****p&#8201;&lt;</italic>&#8201;0.0001, <italic toggle="yes">***p&#8201;&lt;</italic>&#8201;0.001, <italic toggle="yes">**p&#8201;&lt;</italic>&#8201;0.01 vs. silica group; <sup>
<italic toggle="yes">++++</italic>
</sup>
<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001, <sup>
<italic toggle="yes">+++</italic>
</sup>
<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.001, <sup>
<italic toggle="yes">++</italic>
</sup>
<italic toggle="yes">p&#8201;&lt;&#8201;0.01</italic> vs. <italic toggle="yes">Mycobacterium</italic> group.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="AME2-8-1186-g008.jpg"/></fig></sec><sec id="ame270055-sec-0028"><label>3.4</label><title>Diosgenin reduced the mycobacterium colony&#8208;forming units (<styled-content style="fixed-case" toggle="no">CFUs</styled-content>)</title><p>Diosgenin significantly reduced the number of viable bacteria in the lung tissue homogenate after infection with <italic toggle="yes">Mycobacterium smegmatis</italic> to 10.81&#8201;&#177;&#8201;1.748 mycobacteria CFU/mL (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001), compared with the control. Addition of 10&#8201;mg/kg rifampicin resulted in significant growth inhibition of bacterial cells with a mean difference of 9.130&#8201;&#177;&#8201;1.748 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001). Diosgenin inhibited the growth of <italic toggle="yes">Mycobacterium smegmatis</italic> to 1.030&#8201;&#177;&#8201;1.748 (<italic toggle="yes">p&#8201;=</italic>&#8201;0.9633), 2.140&#8201;&#177;&#8201;1.748 (<italic toggle="yes">p&#8201;=</italic>&#8201;0.6257) and 3.370&#8201;&#177;&#8201;1.748 mycobacterium CFU/mL (<italic toggle="yes">p&#8201;=</italic>&#8201;0.2342) at doses of 1, 10 and 20&#8201;mg/kg, respectively, with an F value of 13.14 (Figure&#160;<xref rid="ame270055-fig-0002" ref-type="fig">2</xref>).</p><fig position="float" fig-type="FIGURE" id="ame270055-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Effect of diosgenin on Mycobacterium colony&#8208;forming units. Diosgenin reduced the number of viable bacteria in the lung tissue homogenate. The data are expressed as mean&#8201;&#177;&#8201;SEM. <italic toggle="yes">n</italic>&#8201;=&#8201;10, one&#8208;way ANOVA and Dunnett's post hoc test. **<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01, ***<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, ****<italic toggle="yes">p&#8201;&lt;&#8201;0.0001</italic> vs. <italic toggle="yes">Mycobacterium</italic> induction.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="AME2-8-1186-g005.jpg"/></fig></sec><sec id="ame270055-sec-0029"><label>3.5</label><title>Antioxidant effect of diosgenin</title><sec id="ame270055-sec-0030"><label>3.5.1</label><title>Diosgenin elevated <styled-content style="fixed-case" toggle="no">SOD</styled-content> level</title><p>The antioxidant effect of diosgenin was significantly reduced after the silica challenge, with a mean difference of &#8722;0.1992&#8201;&#177;&#8201;0.01363&#8201;U/mg protein compared to the naive control group (<italic toggle="yes">p&#8201;&lt;&#8201;0.05</italic>). Administration of 10&#8201;mg/kg prednisolone resulted in a decline of &#8722;0.122&#8201;&#177;&#8201;0.01363&#8201;U/mg protein (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001). Diosgenin increased the activity of superoxide dismutase by mean values of &#8722;0.1355&#8201;&#177;&#8201;0.01363 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001), &#8722;0.1451&#8201;&#177;&#8201;0.01363 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001) and&#8201;&#8722;&#8201;0.1970&#8201;&#177;&#8201;0.01363&#8201;U/mg protein (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001) at doses of 1, 10 and 20&#8201;mg/kg, respectively.</p><p>The <italic toggle="yes">Mycobacterium</italic> plus silica group showed significant levels of enzyme activity, with a mean difference of &#8722;0.1000&#8201;&#177;&#8201;0.001825&#8201;U/mg protein (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.05) (Figure&#160;<xref rid="ame270055-fig-0003" ref-type="fig">3</xref>). Rifampicin (10&#8201;mg/kg) resulted in significant enzyme activity, with a mean difference &#8722;0.2641&#8201;&#177;&#8201;0.001825 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.05). Similarly, diosgenin administration led to improvements in superoxide dismutase activity of &#8722;0.09527&#8201;&#177;&#8201;0.001825 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001), &#8722;0.152&#8201;&#177;&#8201;0.001825 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001) and&#8201;&#8722;&#8201;0.2327&#8201;&#177;&#8201;0.001825 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001) at doses of 1, 10 and 20&#8201;mg/kg, respectively, with an <italic toggle="yes">F</italic> value of 20.65 (Figure&#160;<xref rid="ame270055-fig-0003" ref-type="fig">3</xref>).</p><fig position="float" fig-type="FIGURE" id="ame270055-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>Effect of diosgenin on superoxide dismutase activity.&#160;The data are expressed as mean&#8201;&#177;&#8201;SEM. <italic toggle="yes">n</italic>&#8201;=&#8201;10, one&#8208;way ANOVA and Dunnett's post hoc test. <italic toggle="yes">****p&#8201;&lt;</italic>&#8201;0.0001 vs. silica only group; <sup>
<italic toggle="yes">++++</italic>
</sup>
<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001 vs. <italic toggle="yes">Mycobacterium</italic> induction.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="AME2-8-1186-g006.jpg"/></fig></sec><sec id="ame270055-sec-0031"><label>3.5.2</label><title>Diosgenin elevated <styled-content style="fixed-case" toggle="no">CAT</styled-content> levels</title><p>The ability of catalase to break down hydrogen peroxide was significantly reduced after the silica challenge compared with the control group, with a mean difference of &#8722;0.5213&#8201;&#177;&#8201;0.05311&#8201;U/mg protein (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001) Administration of 10&#8201;mg/kg prednisolone increased catalase activity by &#8722;1.493&#8201;&#177;&#8201;0.05311&#8201;U/mg protein (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001). Diosgenin also increased the activity of catalase by mean values of &#8722;0.1506&#8201;&#177;&#8201;0.0531 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001), &#8722;0.6329&#8201;&#177;&#8201;0.05311 (<italic toggle="yes">p&#8201;=</italic>&#8201;0.431) and&#8201;&#8722;&#8201;0.9318&#8201;&#177;&#8201;0.05311&#8201;U/mg protein (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001) at doses of 1, 10 and 20&#8201;mg/kg, respectively, with an <italic toggle="yes">F</italic> value of 209.0.</p><p>The <italic toggle="yes">Mycobacterium</italic> plus silica group recorded significant levels of enzyme activity, with a mean difference of &#8722;0.5723&#8201;&#177;&#8201;0.04207 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001). Rifampicin (10&#8201;mg/kg) resulted in considerable enzyme activity, with a mean difference of &#8722;0.9594&#8201;&#177;&#8201;0.04207 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001). Diosgenin administration led to improvements in antioxidant activity of &#8722;0.1369&#8201;&#177;&#8201;0.04207 (<italic toggle="yes">p&#8201;=</italic>&#8201;0.0181), &#8722;0.4052&#8201;&#177;&#8201;0.04207 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.01) and&#8201;&#8722;&#8201;0.8689&#8201;&#177;&#8201;0.04207&#8201;U/mg protein (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001) at doses of 1, 10 and 20&#8201;mg/kg, respectively, with an F value of 20.65 (Figure&#160;<xref rid="ame270055-fig-0004" ref-type="fig">4</xref>).</p><fig position="float" fig-type="FIGURE" id="ame270055-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>Effect of diosgenin on catalase activity. The data are expressed as mean&#8201;&#177;&#8201;SEM. <italic toggle="yes">n</italic>&#8201;=&#8201;10, one&#8208;way ANOVA and Dennett's post hoc test <italic toggle="yes">*p&#8201;&lt;</italic>&#8201;0.1, <italic toggle="yes">***p&#8201;&lt;</italic>&#8201;0.001 vs. silica&#8208;only group; <sup>+</sup>
<italic toggle="yes">p&#8201;=</italic>&#8201;0.01, <sup>
<italic toggle="yes">+++</italic>
</sup>
<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.001 vs. <italic toggle="yes">Mycobacterium</italic> induction.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="AME2-8-1186-g001.jpg"/></fig></sec><sec id="ame270055-sec-0032"><label>3.5.3</label><title>Diosgenin reduced <styled-content style="fixed-case" toggle="no">MDA</styled-content> levels</title><p>Oxidative stress status was associated with a state of inflammation, as indicated by a significant elevation of malondialdehyde levels (65.96&#8201;&#177;&#8201;3.869&#8201;nmol/mg protein) compared to the naive control group (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.05). Prednisolone (10&#8201;mg/kg) reduced MDA levels to 127.7&#8201;&#177;&#8201;3.869&#8201;nmol/mg protein (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001) compared with the silica&#8208;only group. Diosgenin significantly reduced the mean MDA levels by 24.17&#8201;&#177;&#8201;3.869 (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001), 34.10&#8201;&#177;&#8201;3.869 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.01) and 141.1&#8201;&#177;&#8201;3.869&#8201;nmol/mg protein (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001) at doses of 1, 10 and 20&#8201;mg/kg, respectively. The <italic toggle="yes">F</italic> value was 442.9.</p><p>The <italic toggle="yes">Mycobacterium</italic> plus silica group showed significant levels of MDA, with a mean difference of 69.13&#8201;&#177;&#8201;5.261&#8201;nmol/mg protein (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001). Rifampicin (10&#8201;mg/kg) resulted in a significant reduction in oxidative stress markers, with a value of 63.90&#8201;&#177;&#8201;5.261&#8201;nmol/mg protein (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.0001). Similarly, diosgenin administration reduced MDA levels to 22.64&#8201;&#177;&#8201;5.261 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.01), 34.27&#8201;&#177;&#8201;5.261 (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.01) and 67.98&#8201;&#177;&#8201;5.261&#8201;nmol/mg protein (<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.01) at doses of 1, 10 and 20&#8201;mg/kg, respectively, with a reported <italic toggle="yes">F</italic> value of 59.01 (Figure&#160;<xref rid="ame270055-fig-0005" ref-type="fig">5</xref>).</p><fig position="float" fig-type="FIGURE" id="ame270055-fig-0005" orientation="portrait"><label>FIGURE 5</label><caption><p>Effect of diosgenin on lipid peroxidation. The data are expressed as mean&#8201;&#177;&#8201;SEM. <italic toggle="yes">n</italic>&#8201;=&#8201;10, one&#8208;way ANOVA, and Dunnett's post hoc test. <italic toggle="yes">**p&#8201;&lt;</italic>&#8201;0.01, <italic toggle="yes">*p&#8201;&lt;</italic>&#8201;0.1 vs. silica group; <sup>
<italic toggle="yes">++</italic>
</sup>
<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.01, <sup>+</sup>
<italic toggle="yes">p&#8201;&lt;</italic>&#8201;0.1 vs. mycobacterium induction.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-11" orientation="portrait" xlink:href="AME2-8-1186-g003.jpg"/></fig></sec></sec><sec id="ame270055-sec-0033"><label>3.6</label><title>Histological findings</title><sec id="ame270055-sec-0034"><label>3.6.1</label><title>Microscopic findings with H&amp;E stain</title><p>Hematoxylin and Eosin stain were used to differentiate between types of connective tissue and fibers. Hematoxylin is a basic dye that stains the acidic component of wax&#8208;cleared tissue, while the acidic Eosin stains the fundamental component of the tissue. The normal control (A) is lung tissue composed microscopically of patent alveolar spaces. Blood vessels are not congested. There is no infiltration of inflammatory cells, typical of normal lung tissue. In Figure&#160;<xref rid="ame270055-fig-0006" ref-type="fig">6B</xref>, the lung tissue shows extensive damage to the parenchyma. There is evidence of massive necrotic debris (pus formation). The underlying lymph nodes show evidence of reactive sinus hyperplasia. In Figure&#160;<xref rid="ame270055-fig-0006" ref-type="fig">6C</xref>, diosgenin administration at a dose of 1&#8201;mg/kg shows lymph node activation and infiltration of inflammatory cells. In Figure&#160;<xref rid="ame270055-fig-0006" ref-type="fig">6D</xref>, the 10&#8201;mg/kg dose of diosgenin depicts mild to moderate lung parenchyma destruction with patent alveoli. In Figure&#160;<xref rid="ame270055-fig-0006" ref-type="fig">6E</xref>, 20&#8201;mg/kg diosgenin and 10&#8201;mg/kg prednisolone show moderately healed lung parenchyma. The alveoli spaces are patent. Findings are most consistent with a healed lung parenchyma (Figure&#160;<xref rid="ame270055-fig-0006" ref-type="fig">6</xref>).</p><fig position="float" fig-type="FIGURE" id="ame270055-fig-0006" orientation="portrait"><label>FIGURE 6</label><caption><p>Representative photomicrograph of a section of lung tissue (H&amp;E stain) (A) control; (B) silica plus <italic toggle="yes">Mycobacterium</italic>; (C) 1&#8201;mg/kg diosgenin; (D) 10&#8201;mg/kg diosgenin; (E) 20&#8201;mg/kg diosgenin; (F) prednisolone 10&#8201;mg/kg. AS, alveoli space; CB, congested blood vessels; IC, inflammatory; LA, lymph activation. Magnification &#215;10.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-13" orientation="portrait" xlink:href="AME2-8-1186-g004.jpg"/></fig></sec><sec id="ame270055-sec-0035"><label>3.6.2</label><title>Microscopic findings with Van Gieson stain</title><p>Van Gieson stain was used to differentiate collagen fibers from muscle and red blood cells. The collagen fiber is stained red and smooth, and the striated muscle is stained yellow. The control showed standard lung architecture with ciliated thin epithelium lining the terminal bronchi. Silica plus <italic toggle="yes">Mycobacterium</italic> showed extensive infiltration of necrotic debris into the alveolar space. Terminal bronchi are shrunken with eroded cilia. At 1&#8201;mg/kg, diosgenin shows infiltration of cells into the alveolar space. Collagen fibers are visible. Administration of 20 and 10&#8201;mg/kg diosgenin shows moderately healed lung parenchyma with few remnants of inflammatory cells (Figure&#160;<xref rid="ame270055-fig-0007" ref-type="fig">7</xref>).</p><fig position="float" fig-type="FIGURE" id="ame270055-fig-0007" orientation="portrait"><label>FIGURE 7</label><caption><p>Representative photomicrograph of a section of lung tissue (Van Gieson stain) (A) control; (B) silica plus <italic toggle="yes">Mycobacterium</italic>; (C) 1&#8201;mg/kg diosgenin; (D) 10&#8201;mg/kg diosgenin; (E) 20&#8201;mg/kg diosgenin; (F) 10&#8201;mg/kg rifampicin. CF, collagen fibers; H, hyalin; SM, smooth muscle. Magnification &#215;10.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-15" orientation="portrait" xlink:href="AME2-8-1186-g002.jpg"/></fig></sec></sec></sec><sec sec-type="discussion" id="ame270055-sec-0036"><label>4</label><title>DISCUSSION</title><p>Silicosis is a work&#8208;related lung disease caused by excessive exposure to silica. It results in irreversible and serious health effects in silica&#8208;exposed workers. Silica&#8208;induced fibrosis remains the most reliable and frequently used experimental model of silicosis.<xref rid="ame270055-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="ame270055-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> In this regard, we sought to investigate the ability of diosgenin to inhibit the growth of <italic toggle="yes">Mycobacterium smegmatis</italic> and its antioxidant potential in the treatment of silica&#8208;induced tuberculosis. The study was supported by a histological examination of the lung tissue, which employed the use of Hematoxylin and Eosin and Van Gieson stains.</p><p>According to the results in Table&#160;<xref rid="ame270055-tbl-0001" ref-type="table">1</xref>, diosgenin inhibited the growth of <italic toggle="yes">Mycobacterium smegmatis</italic> with an IC<sub>50</sub> value of 0.006043&#8201;&#956;g/mL (<italic toggle="yes">r</italic>&#8201;=&#8201;0.86). Interestingly, the mainstream standard drugs recorded IC<sub>50</sub> values of 0.1192 and 52.55&#8201;&#956;g/mL for isoniazid and rifampicin, respectively. Hence, our findings (Table&#160;<xref rid="ame270055-tbl-0001" ref-type="table">1</xref>) suggest diosgenin could be more potent than isoniazid and rifampicin. In a previous study,<xref rid="ame270055-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> diosgenin exhibited similar antibacterial effects through inhibition of biofilms, the means by which bacteria become resistant to antimicrobial agents.<xref rid="ame270055-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> The mechanism by which diosgenin exerts this antibacterial effect is still unclear, but it may involve disrupting bacterial cell wall synthesis, inhibiting biofilm formation, or modulating immune responses. A significant improvement can be made by studying the synergistic ability of diosgenin with one of the mainstream antitubercular drugs. Diosgenin could be developed as a potential adjunct to the current antitubercular agents in the fight against multidrug&#8208;resistant tuberculosis.</p><p>Weight loss is a hallmark of chronic inflammation and tuberculosis. Diosgenin's effect may be linked to its ability to modulate inflammatory pathways and reduce oxidative stress, preventing excessive muscle wasting. Previous studies have shown that diosgenin exhibits anti&#8208;inflammatory properties by inhibiting pro&#8208;inflammatory cytokines (TNF&#8208;&#945;, IL&#8208;6) and reducing oxidative stress.<xref rid="ame270055-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>
</p><p>Loss of pulmonary membrane integrity was indicated by the infiltration of cells and fluid into the lung parenchyma. Increases in lung weight and the ratio of wet to dry lung weights and were used to indicate pathological changes in the lung.<xref rid="ame270055-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> In a previous study, silica induction led to oxidative stress and mitochondrial membrane dysfunction in lung epithelial cells.<xref rid="ame270055-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>
</p><p>The ability of superoxide dismutase to break the harmful oxygen molecule into a less damaging form is an essential factor in immune defense. The increase in the antioxidant activity of diosgenin may be due to its ability to activate the endogenous antioxidant level.<xref rid="ame270055-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> In similar studies,<xref rid="ame270055-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> the observation was supported by a relative reduction in oxidative damage in a feed containing diosgenin. Rats supplemented with 0.1 and 0.5% diosgenin powder in a feed showed enhanced resistance to DNA damage and suppressed weight gain.</p><p>Catalase is an enzyme present in nearly all living organisms. It breaks down hydrogen peroxide produced as a result of cellular respiration into water and oxygen.<xref rid="ame270055-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> Antioxidant activity was quantified after silica and <italic toggle="yes">Mycobacterium</italic> administration. An increase in enzyme activation corresponded to a reduction of mucus accumulation in the lung tissue. This finding is consistent with previous work, where a 40&#8201;mg/kg dose of diosgenin had a pronounced effect on enzyme activation compared to the 20&#8201;mg/kg dose in the present study. The difference may be due to the variable length of diosgenin administration and the dosage. Administration of diosgenin is linked to rebuilding endogenous antioxidant capacity after silica lung damage.<xref rid="ame270055-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref>, <xref rid="ame270055-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref>
</p><p>MDA levels were quantified to determine the extent of damage caused by the oxidative degradation of unsaturated fatty acids in the cell membrane. Diosgenin administration resulted in a significant reduction in MDA levels, indicating its potential to inhibit mitochondrial membrane impairment. Our findings suggest that using diosgenin as an antioxidant supplement may be useful in protecting against oxidative stress in patients with compromised immune defenses due to mitochondrial membrane irritation. The above result is consistent with previous studies<xref rid="ame270055-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref>, <xref rid="ame270055-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref> in which 40&#8201;mg/kg of diosgenin led to a decline in the level of MDA in impaired mitochondrial oxidative stress. In another study,<xref rid="ame270055-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> diosgenin defended the bio membranes of mice fed a high&#8208;fat diet through a decline of lipid peroxidation.</p><p>Massive destruction of the lung parenchyma was observed in the Van Gieson&#8208;stained tissue compared to the H&amp;E. From Figures&#160;<xref rid="ame270055-fig-0006" ref-type="fig">6</xref> and <xref rid="ame270055-fig-0007" ref-type="fig">7</xref>, it can be deduced that the wall of the granuloma formed by cellular infiltration of infected immune cells got raptured, releasing the contents into the lymphatic vessel which led to activation of the lymph node. In a previous study, diosgenin administration in H&amp;E&#8208;stained sciatic nerve restored tissue damage through the antioxidant defense system.<xref rid="ame270055-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref> In our study, the maximum dose resulted in a significant improvement in lung healing. The degree of inflammation in the 20&#8201;mg/kg group was significantly reduced (Figure&#160;<xref rid="ame270055-fig-0006" ref-type="fig">6</xref>). To achieve the maximum healing effect of diosgenin, it is therefore recommended that the treatment be continued for more than 50&#8201;days. The number of inflammatory cells was not quantified, and the data do not include the type of collagen fibers involved.</p><p>In brief, silica&#8208;induced damage to alveolar macrophages and mycobacterial infection may play a crucial role in the progression of oxidative damage in the lung parenchyma. Diosgenin administration led to a significant improvement in pulmonary function, characterized by a decline in oxidative damage and inhibition of mycobacterial growth, and therefore has the potential to be developed as a drug to combat silicotuberculosis.</p></sec><sec sec-type="conclusions" id="ame270055-sec-0038"><label>5</label><title>CONCLUSION</title><p>Diosgenin attenuated lung injury through inhibition of <italic toggle="yes">Mycobacterium smegmatis</italic> growth, a decline in malondialdehyde levels and elevation of antioxidant enzymes. The compound, therefore, represents an interesting alternative means of treating lung fibrosis and can serve as a useful lead compound for the development of a drug to tackle silica&#8208;induced tuberculosis.</p></sec><sec id="ame270055-sec-0045"><title>AUTHOR CONTRIBUTIONS</title><p>
<bold>Williams Asamoah Adu:</bold> Conceptualization; formal analysis; methodology. <bold>Paul Poku Sampene Ossei:</bold> Project administration; resources; supervision. <bold>Cynthia Amaning Danquah:</bold> Project administration; resources; supervision. <bold>Selase Ativui:</bold> Conceptualization; methodology. <bold>Michael Ofori:</bold> Formal analysis; validation. <bold>George Owusu:</bold> Validation; visualization; writing &#8211; review and editing.</p></sec><sec id="ame270055-sec-0040"><title>FUNDING INFORMATION</title><p>None.</p></sec><sec sec-type="COI-statement" id="ame270055-sec-0041"><title>CONFLICT OF INTEREST STATEMENT</title><p>The authors declare no competing interest.</p></sec><sec id="ame270055-sec-0042"><title>ETHICS STATEMENT</title><p>Ethical approval (FPPS/008/2018) was obtained from the Department of Pharmacology, Animal Ethics Committee, KNUST, Kumasi, Ghana.</p></sec></body><back><ack id="ame270055-sec-0039"><title>ACKNOWLEDGMENTS</title><p>The authors thank all members of the drug discovery and cell culture lab for their immense contribution and all the technicians at the Pharmacology lab, Faculty of Pharmacy and Pharmaceutical Science, KNUST.</p></ack><sec sec-type="data-availability" id="ame270055-sec-0044"><title>DATA AVAILABILITY STATEMENT</title><p>The data that supports the findings of this study are available in the supplementary material of this article.</p></sec><ref-list content-type="cited-references" id="ame270055-bibl-0001"><title>REFERENCES</title><ref id="ame270055-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="ame270055-cit-0001"><string-name name-style="western"><surname>Guo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Bo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Shao</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></string-name>. <article-title>Pirfenidone inhibits epithelial&#8208;mesenchymal transition and pulmonary fibrosis in the rat silicosis model</article-title>. <source>Toxicol Lett</source>. <year>2019</year>;<volume>300</volume>:<fpage>59</fpage>&#8208;<lpage>66</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.toxlet.2018.10.019</pub-id><pub-id pub-id-type="pmid">30394303</pub-id></mixed-citation></ref><ref id="ame270055-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="ame270055-cit-0002"><string-name name-style="western"><surname>Armah</surname><given-names>E</given-names></string-name>. <article-title>Level of exposure of occupational respirable dust to underground gold mine Workers in Ghana</article-title>. <source>Global Environ Health Safety</source>. <year>2017</year>;<volume>9</volume>:<elocation-id>2156</elocation-id>.</mixed-citation></ref><ref id="ame270055-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="ame270055-cit-0003"><string-name name-style="western"><surname>Huang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>F</given-names></string-name>, et&#160;al. <article-title>N&#8208;acetylcysteine tiherapeutically protects against pulmonary fibrosis in a mouse model of silicosis</article-title>. <source>Biosci Rep</source>. <year>2019</year>;<volume>39</volume>(<issue>7</issue>):<elocation-id>681</elocation-id>. doi:<pub-id pub-id-type="doi">10.1042/bsr20190681</pub-id><pub-id pub-id-type="pmcid">PMC6639458</pub-id><pub-id pub-id-type="pmid">31273057</pub-id></mixed-citation></ref><ref id="ame270055-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="ame270055-cit-0004"><string-name name-style="western"><surname>Beamer</surname><given-names>GL</given-names></string-name>, <string-name name-style="western"><surname>Seaver</surname><given-names>BP</given-names></string-name>, <string-name name-style="western"><surname>Jessop</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Shepherd</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Beamer</surname><given-names>CA</given-names></string-name>. <article-title>Acute exposure to crystalline silica reduces macrophage activation in response to bacterial lipoproteins</article-title>. <source>Front Immunol</source>. <year>2016</year>;<volume>7</volume>:<fpage>49</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2016.00049</pub-id><pub-id pub-id-type="pmid">26913035</pub-id><pub-id pub-id-type="pmcid">PMC4753301</pub-id></mixed-citation></ref><ref id="ame270055-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="ame270055-cit-0005"><string-name name-style="western"><surname>Ehrlich</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Akugizibwe</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Siegfried</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Rees</surname><given-names>D</given-names></string-name>. <article-title>The association between silica exposure, silicosis and tuberculosis: a systematic review and meta&#8208;analysis</article-title>. <source>BMC Public Health</source>. <year>2021</year>;<volume>21</volume>(<issue>1</issue>):<fpage>953</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12889-021-10711-1</pub-id><pub-id pub-id-type="pmid">34016067</pub-id><pub-id pub-id-type="pmcid">PMC8136154</pub-id></mixed-citation></ref><ref id="ame270055-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="ame270055-cit-0006"><string-name name-style="western"><surname>Habybabady</surname><given-names>RH</given-names></string-name>, <string-name name-style="western"><surname>Sis</surname><given-names>HN</given-names></string-name>, <string-name name-style="western"><surname>Paridokht</surname><given-names>F</given-names></string-name>, et&#160;al. <article-title>Effects of dust exposure on the respiratory health symptoms and pulmonary functions of street sweepers</article-title>. <source>Malays J Med Sci</source>. <year>2018</year>;<volume>25</volume>(<issue>6</issue>):<fpage>76</fpage>&#8208;<lpage>84</lpage>. doi:<pub-id pub-id-type="doi">10.21315/mjms2018.25.6.8</pub-id><pub-id pub-id-type="pmid">30914881</pub-id><pub-id pub-id-type="pmcid">PMC6422576</pub-id></mixed-citation></ref><ref id="ame270055-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="ame270055-cit-0007"><string-name name-style="western"><surname>Kusaczuk</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kr&#281;towski</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Naumowicz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Stypu&#322;kowska</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Cechowska&#8208;Pasko</surname><given-names>M</given-names></string-name>. <article-title>Silica nanoparticle&#8208;induced oxidative stress and mitochondrial damage is followed by activation of intrinsic apoptosis pathway in glioblastoma cells</article-title>. <source>Int J Nanomedicine</source>. <year>2018</year>;<volume>13</volume>:<fpage>2279</fpage>&#8208;<lpage>2294</lpage>. doi:<pub-id pub-id-type="doi">10.2147/IJN.S158393</pub-id><pub-id pub-id-type="pmid">29695906</pub-id><pub-id pub-id-type="pmcid">PMC5905826</pub-id></mixed-citation></ref><ref id="ame270055-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="ame270055-cit-0008"><string-name name-style="western"><surname>Lopes&#8208;Pacheco</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Melo</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Morales</surname><given-names>M</given-names></string-name>. <article-title>Cell&#8208;based therapy for silicosis</article-title>. <source>Stem Cells Int</source>. <year>2016</year>;<volume>20</volume>:<fpage>1</fpage>&#8208;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1155/2016/5091838</pub-id><pub-id pub-id-type="pmcid">PMC4811211</pub-id><pub-id pub-id-type="pmid">27066079</pub-id></mixed-citation></ref><ref id="ame270055-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="ame270055-cit-0009"><string-name name-style="western"><surname>Chen</surname><given-names>YJ</given-names></string-name>, <string-name name-style="western"><surname>Yao</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>Lipopolysaccharides may aggravate apoptosis through accumulation of autophagosomes in alveolar macrophages of human silicosis</article-title>. <source>Autophagy</source>. <year>2015</year>;<volume>11</volume>(<issue>12</issue>):<fpage>2346</fpage>&#8208;<lpage>2357</lpage>. doi:<pub-id pub-id-type="doi">10.1080/15548627.2015.1109765</pub-id><pub-id pub-id-type="pmid">26553601</pub-id><pub-id pub-id-type="pmcid">PMC4835201</pub-id></mixed-citation></ref><ref id="ame270055-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="ame270055-cit-0010"><string-name name-style="western"><surname>Kasapoglu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ozben</surname><given-names>T</given-names></string-name>. <article-title>Alterations of antioxidant enzymes and oxidative stress markers in aging</article-title>. <source>Exp Gerontol</source>. <year>2001</year>;<volume>36</volume>(<issue>2</issue>):<fpage>209</fpage>&#8208;<lpage>220</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0531-5565(00)00198-4</pub-id><pub-id pub-id-type="pmid">11226737</pub-id></mixed-citation></ref><ref id="ame270055-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="ame270055-cit-0011"><string-name name-style="western"><surname>Lelovic</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Mitachi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lemieux</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Ji</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kurosu</surname><given-names>M</given-names></string-name>. <article-title>Application of mycobacterium smegmatis as a surrogate to evaluate drug leads against mycobacterium tuberculosis</article-title>. <source>J Antibiot</source>. <year>2020</year>;<volume>73</volume>(<issue>11</issue>):<fpage>780</fpage>&#8208;<lpage>789</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41429-020-0320-7</pub-id><pub-id pub-id-type="pmcid">PMC7554168</pub-id><pub-id pub-id-type="pmid">32472054</pub-id></mixed-citation></ref><ref id="ame270055-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="ame270055-cit-0012"><string-name name-style="western"><surname>Gupta</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bhakta</surname><given-names>S</given-names></string-name>. <article-title>An integrated surrogate model for screening of drugs against mycobacterium tuberculosis</article-title>. <source>J Antimicrob Chemother</source>. <year>2012</year>;<volume>67</volume>:<fpage>1380</fpage>&#8208;<lpage>1391</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dks056</pub-id><pub-id pub-id-type="pmid">22398649</pub-id></mixed-citation></ref><ref id="ame270055-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="ame270055-cit-0013"><string-name name-style="western"><surname>Ofori</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Amaning Danquah</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ativui</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Doe</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Asamoah</surname><given-names>W</given-names></string-name>. <article-title>In&#8208;vitro anti&#8208;tuberculosis, anti&#8208;efflux pumps and anti&#8208;biofilm effects of crinum Asiaticum bulbs</article-title>. <source>Biomed Pharmacol J</source>. <year>2021</year>;<volume>14</volume>:<fpage>1905</fpage>&#8208;<lpage>1915</lpage>. doi:<pub-id pub-id-type="doi">10.13005/bpj/2289</pub-id></mixed-citation></ref><ref id="ame270055-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="ame270055-cit-0014"><string-name name-style="western"><surname>Du</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Dioscin alleviates crystalline silica&#8208;induced pulmonary inflammation and fibrosis through promoting alveolar macrophage autophagy</article-title>. <source>Theranostics</source>. <year>2019</year>;<volume>9</volume>(<issue>7</issue>):<fpage>1878</fpage>&#8208;<lpage>1892</lpage>. doi:<pub-id pub-id-type="doi">10.7150/thno.29682</pub-id><pub-id pub-id-type="pmid">31037145</pub-id><pub-id pub-id-type="pmcid">PMC6485284</pub-id></mixed-citation></ref><ref id="ame270055-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="ame270055-cit-0015"><string-name name-style="western"><surname>Zheng</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Cox</surname><given-names>IA</given-names></string-name>, <string-name name-style="western"><surname>Campbell</surname><given-names>JA</given-names></string-name>, et&#160;al. <article-title>Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta&#8208;analysis</article-title>. <source>ERJ Open Res</source>. <year>2022</year>;<volume>20</volume>:<fpage>591</fpage>&#8208;<lpage>598</lpage>. doi:<pub-id pub-id-type="doi">10.1183/23120541.00591-2021</pub-id><pub-id pub-id-type="pmcid">PMC8918939</pub-id><pub-id pub-id-type="pmid">35295232</pub-id></mixed-citation></ref><ref id="ame270055-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="ame270055-cit-0016"><string-name name-style="western"><surname>Dineshbabu</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Ananda sadagopan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ganapasam</surname><given-names>S</given-names></string-name>. <article-title>Diosgenin inhibits TGF&#8208;&#946;1/Smad signaling and regulates epithelial mesenchymal transition in experimental pulmonary fibrosis</article-title>. <source>Drug Chem Toxicol</source>. <year>2020</year>;<volume>25</volume>:<fpage>1</fpage>&#8208;<lpage>13</lpage>. doi:<pub-id pub-id-type="doi">10.1080/01480545.2020.1814803</pub-id><pub-id pub-id-type="pmid">32924642</pub-id></mixed-citation></ref><ref id="ame270055-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="ame270055-cit-0017"><string-name name-style="western"><surname>Marijic</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Schwarzkopf</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Schwettmann</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Ruhnke</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Trudzinski</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Kreuter</surname><given-names>M</given-names></string-name>. <article-title>Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study</article-title>. <source>Respir Res</source>. <year>2021</year>;<volume>22</volume>(<issue>1</issue>):<fpage>268</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12931-021-01857-y</pub-id><pub-id pub-id-type="pmid">34666765</pub-id><pub-id pub-id-type="pmcid">PMC8527681</pub-id></mixed-citation></ref><ref id="ame270055-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="ame270055-cit-0018"><string-name name-style="western"><surname>Jesus</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Martins</surname><given-names>APJ</given-names></string-name>, <string-name name-style="western"><surname>Gallardo</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Silvestre</surname><given-names>S</given-names></string-name>. <article-title>Diosgenin: recent highlights on pharmacology and analytical methodology</article-title>. <source>J Anal Methods Chem</source>. <year>2016</year>;<volume>2016</volume>:<elocation-id>4156293</elocation-id>. doi:<pub-id pub-id-type="doi">10.1155/2016/4156293</pub-id><pub-id pub-id-type="pmid">28116217</pub-id><pub-id pub-id-type="pmcid">PMC5225340</pub-id></mixed-citation></ref><ref id="ame270055-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="ame270055-cit-0019"><string-name name-style="western"><surname>Danquah</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Maitra</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gibbons</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Faull</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Bhakta</surname><given-names>S</given-names></string-name>. <article-title>HT&#8208;SPOTi: a rapid drug susceptibility test (DST) to evaluate antibiotic resistance profiles and novel Chemicals for Anti&#8208;Infective Drug Discovery</article-title>. <source>Curr Protoc Microbiol</source>. <year>2016</year>;<volume>40</volume>(<issue>8</issue>):<fpage>1</fpage>&#8208;<lpage>12</lpage>. doi:<pub-id pub-id-type="doi">10.1002/9780471729259.mc1708s40</pub-id><pub-id pub-id-type="pmid">26855282</pub-id></mixed-citation></ref><ref id="ame270055-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="ame270055-cit-0020"><string-name name-style="western"><surname>Cruz</surname><given-names>FF</given-names></string-name>, <string-name name-style="western"><surname>Horta</surname><given-names>LF</given-names></string-name>, <string-name name-style="western"><surname>Maia</surname><given-names>LA</given-names></string-name>, et&#160;al. <article-title>Dasatinib reduces lung inflammation and fibrosis in acute experimental silicosis</article-title>. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>(<issue>1</issue>):<elocation-id>e0147005</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0147005</pub-id><pub-id pub-id-type="pmid">26789403</pub-id><pub-id pub-id-type="pmcid">PMC4720427</pub-id></mixed-citation></ref><ref id="ame270055-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="ame270055-cit-0021"><string-name name-style="western"><surname>Mayeux</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Kono</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Pollard</surname><given-names>KM</given-names></string-name>. <article-title>Development of experimental silicosis in inbred and outbred mice depends on instillation volume</article-title>. <source>Sci Rep</source>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<elocation-id>14190</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/s41598-019-50725-9</pub-id><pub-id pub-id-type="pmid">31578388</pub-id><pub-id pub-id-type="pmcid">PMC6775097</pub-id></mixed-citation></ref><ref id="ame270055-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="ame270055-cit-0022"><string-name name-style="western"><surname>Zhao</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Lv</surname><given-names>R</given-names></string-name>, et&#160;al. <article-title>Transcriptome profile analysis reveals a silica&#8208;induced immune response and fibrosis in a silicosis rat model</article-title>. <source>Toxicol Lett</source>. <year>2020</year>;<volume>333</volume>:<fpage>42</fpage>&#8208;<lpage>48</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.toxlet.2020.07.021</pub-id><pub-id pub-id-type="pmid">32721576</pub-id></mixed-citation></ref><ref id="ame270055-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="ame270055-cit-0023"><string-name name-style="western"><surname>dos Santos</surname><given-names>ACD</given-names></string-name>, <string-name name-style="western"><surname>Marinho</surname><given-names>VHS</given-names></string-name>, <string-name name-style="western"><surname>Silva</surname><given-names>PHA</given-names></string-name>, et&#160;al. <article-title>Microenvironment of mycobacterium smegmatis culture to induce cholesterol consumption does Cell Wall remodeling and enables the formation of granuloma&#8208;like structures</article-title>. <source>Biomed Res Int</source>. <year>2019</year>;<volume>2019</volume>:<elocation-id>1871239</elocation-id>. doi:<pub-id pub-id-type="doi">10.1155/2019/1871239</pub-id><pub-id pub-id-type="pmid">31119154</pub-id><pub-id pub-id-type="pmcid">PMC6500705</pub-id></mixed-citation></ref><ref id="ame270055-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="ame270055-cit-0024"><string-name name-style="western"><surname>Shin</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Manning</surname><given-names>EJB</given-names></string-name>, <string-name name-style="western"><surname>Collins</surname><given-names>MT</given-names></string-name>. <article-title>Rapid and reliable method for quantification of mycobacterium paratuberculosis by use of the BACTEC MGIT 960 system</article-title>. <source>J Clin Microbiol</source>. <year>2007</year>;<volume>45</volume>(<issue>6</issue>):<fpage>1941</fpage>&#8208;<lpage>1948</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JCM.02616-06</pub-id><pub-id pub-id-type="pmid">17428943</pub-id><pub-id pub-id-type="pmcid">PMC1933085</pub-id></mixed-citation></ref><ref id="ame270055-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="ame270055-cit-0025"><string-name name-style="western"><surname>Meyer</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Isaksen</surname><given-names>A</given-names></string-name>. <article-title>Application of enzymes as food antioxidants</article-title>. <source>Trends Food Sci Technol</source>. <year>1995</year>;<volume>6</volume>(<issue>9</issue>):<fpage>300</fpage>&#8208;<lpage>304</lpage>.</mixed-citation></ref><ref id="ame270055-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="ame270055-cit-0026"><string-name name-style="western"><surname>Sinha</surname><given-names>AK</given-names></string-name>. <article-title>Colorimetric assay of catalase</article-title>. <source>Anal Biochem</source>. <year>1972</year>;<volume>47</volume>(<issue>2</issue>):<fpage>389</fpage>&#8208;<lpage>394</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0003-2697(72)90132-7</pub-id><pub-id pub-id-type="pmid">4556490</pub-id></mixed-citation></ref><ref id="ame270055-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="ame270055-cit-0027"><string-name name-style="western"><surname>Heath</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Packer</surname><given-names>L</given-names></string-name>. <article-title>Photoperoxidation in isolated chloroplasts: I. Kinetics and stoichiometry of fatty acid peroxidation</article-title>. <source>Arch Biochem Biophys</source>. <year>1968</year>;<volume>125</volume>(<issue>1</issue>):<fpage>189</fpage>&#8208;<lpage>198</lpage>.<pub-id pub-id-type="pmid">5655425</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0003-9861(68)90654-1</pub-id></mixed-citation></ref><ref id="ame270055-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="ame270055-cit-0028"><string-name name-style="western"><surname>Webster</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Kempen</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Hardy</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Langen</surname><given-names>RCJ</given-names></string-name>. <article-title>Inflammation and skeletal muscle wasting during cachexia</article-title>. <source>Front Physiol</source>. <year>2020</year>;<volume>11</volume>:<elocation-id>597675</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fphys.2020.597675</pub-id><pub-id pub-id-type="pmid">33329046</pub-id><pub-id pub-id-type="pmcid">PMC7710765</pub-id></mixed-citation></ref><ref id="ame270055-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="ame270055-cit-0029"><string-name name-style="western"><surname>Honnons</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Porcher</surname><given-names>JM</given-names></string-name>. <article-title>In vivo experimental model for silicosis</article-title>. <source>J Environ Pathol Toxicol Oncol</source>. <year>2000</year>;<volume>19</volume>(<issue>4</issue>):<fpage>391</fpage>&#8208;<lpage>400</lpage>.<pub-id pub-id-type="pmid">11213022</pub-id></mixed-citation></ref><ref id="ame270055-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="ame270055-cit-0030"><string-name name-style="western"><surname>Cai</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Z</given-names></string-name>, et&#160;al. <article-title>Therapeutic potential of diosgenin and its major derivatives against neurological diseases: recent advances</article-title>. <source>Oxid Med Cell Longev</source>. <year>2020</year>;<volume>16</volume>:<elocation-id>3153082</elocation-id>. doi:<pub-id pub-id-type="doi">10.1155/2020/3153082</pub-id><pub-id pub-id-type="pmcid">PMC7079249</pub-id><pub-id pub-id-type="pmid">32215172</pub-id></mixed-citation></ref><ref id="ame270055-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="ame270055-cit-0031"><string-name name-style="western"><surname>Cong</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Tong</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>Q</given-names></string-name>, et&#160;al. <article-title>In vitro anti&#8208;bacterial activity of diosgenin on Porphyromonas gingivalis and Prevotella intermedia</article-title>. <source>Mol Med Rep</source>. <year>2020</year>;<volume>22</volume>(<issue>6</issue>):<fpage>5392</fpage>&#8208;<lpage>5398</lpage>. doi:<pub-id pub-id-type="doi">10.3892/mmr.2020.11620</pub-id><pub-id pub-id-type="pmid">33174005</pub-id><pub-id pub-id-type="pmcid">PMC7647021</pub-id></mixed-citation></ref><ref id="ame270055-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="ame270055-cit-0032"><string-name name-style="western"><surname>Huang</surname><given-names>C&#8208;H</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>C&#8208;C</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>Y&#8208;C</given-names></string-name>, <string-name name-style="western"><surname>Hori</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Jan</surname><given-names>T&#8208;R</given-names></string-name>. <article-title>Oral administration with diosgenin enhances the induction of intestinal T helper 1&#8208;like regulatory T cells in a murine model of food allergy</article-title>. <source>Int Immunopharmacol</source>. <year>2017</year>;<volume>42</volume>:<fpage>59</fpage>&#8208;<lpage>66</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.intimp.2016.11.021</pub-id><pub-id pub-id-type="pmid">27886644</pub-id></mixed-citation></ref><ref id="ame270055-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="ame270055-cit-0033"><string-name name-style="western"><surname>Herrero</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Sanchez</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Lorente</surname><given-names>JA</given-names></string-name>. <article-title>New insights into the mechanisms of pulmonary edema in acute lung injury</article-title>. <source>Annals Transl Med</source>. <year>2018</year>;<volume>6</volume>(<issue>2</issue>):<fpage>32</fpage>. doi:<pub-id pub-id-type="doi">10.21037/atm.2017.12.18</pub-id><pub-id pub-id-type="pmcid">PMC5799138</pub-id><pub-id pub-id-type="pmid">29430449</pub-id></mixed-citation></ref><ref id="ame270055-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="ame270055-cit-0034"><string-name name-style="western"><surname>Zhao</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Abulikemu</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lv</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>Oxidative stress&#8208;and mitochondrial dysfunction&#8208;mediated cytotoxicity by silica nanoparticle in lung epithelial cells from metabolomic perspective</article-title>. <source>Chemosphere</source>. <year>2021</year>;<volume>275</volume>:<elocation-id>129969</elocation-id>.<pub-id pub-id-type="pmid">33662726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chemosphere.2021.129969</pub-id></mixed-citation></ref><ref id="ame270055-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="ame270055-cit-0035"><string-name name-style="western"><surname>Chen</surname><given-names>WZH</given-names></string-name>, <string-name name-style="western"><surname>Hsu</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>HH</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>JH</given-names></string-name>. <article-title>In vivo protective effects of diosgenin against doxorubicin&#8208;induced cardiotoxicity</article-title>. <source>Nutrients</source>. <year>2015</year>;<volume>7</volume>(<issue>6</issue>):<fpage>4938</fpage>&#8208;<lpage>4954</lpage>. doi:<pub-id pub-id-type="doi">10.3390/nu7064938</pub-id><pub-id pub-id-type="pmid">26091236</pub-id><pub-id pub-id-type="pmcid">PMC4488824</pub-id></mixed-citation></ref><ref id="ame270055-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="ame270055-cit-0036"><string-name name-style="western"><surname>Son</surname><given-names>IS</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Sohn</surname><given-names>HY</given-names></string-name>, <string-name name-style="western"><surname>Son</surname><given-names>KH</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Kwon</surname><given-names>CS</given-names></string-name>. <article-title>Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (<italic toggle="yes">Dioscorea</italic> spp.), on high&#8208;cholesterol fed rats</article-title>. <source>Biosci Biotechnol Biochem</source>. <year>2007</year>;<volume>71</volume>(<issue>12</issue>):<fpage>3063</fpage>&#8208;<lpage>3071</lpage>. doi:<pub-id pub-id-type="doi">10.1271/bbb.70472</pub-id><pub-id pub-id-type="pmid">18071250</pub-id></mixed-citation></ref><ref id="ame270055-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="ame270055-cit-0037"><string-name name-style="western"><surname>Kaushal</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mehandia</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Raina</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Arya</surname><given-names>S</given-names></string-name>. <article-title>Catalase enzyme: application in bioremediation and food industry</article-title>. <source>Biocatal Agric Biotechnol</source>. <year>2018</year>;<volume>16</volume>:<elocation-id>35</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.bcab.2018.07.035</pub-id></mixed-citation></ref><ref id="ame270055-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="ame270055-cit-0038"><string-name name-style="western"><surname>Ji</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Z</given-names></string-name>. <article-title>Diosgenin, a novel aldose reductase inhibitor, attenuates the galactosemic cataract in rats</article-title>. <source>J Diabetes Res</source>. <year>2017</year>;<volume>2017</volume>:<elocation-id>7309816</elocation-id>. doi:<pub-id pub-id-type="doi">10.1155/2017/7309816</pub-id><pub-id pub-id-type="pmid">29038789</pub-id><pub-id pub-id-type="pmcid">PMC5605930</pub-id></mixed-citation></ref><ref id="ame270055-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="ame270055-cit-0039"><string-name name-style="western"><surname>Pari</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Monisha</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Mohamed</surname><given-names>JA</given-names></string-name>. <article-title>Beneficial role of diosgenin on oxidative stress in aorta of streptozotocin induced diabetic rats</article-title>. <source>Eur J Pharmacol</source>. <year>2012</year>;<volume>691</volume>(<issue>1&#8211;3</issue>):<fpage>143</fpage>&#8208;<lpage>150</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejphar.2012.06.038</pub-id><pub-id pub-id-type="pmid">22771295</pub-id></mixed-citation></ref><ref id="ame270055-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="ame270055-cit-0040"><string-name name-style="western"><surname>Fang</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>G</given-names></string-name>, et&#160;al. <article-title>Diosgenin ameliorates palmitic acid&#8208;induced lipid accumulation via AMPK/ACC/CPT&#8208;1A and SREBP&#8208;1c/FAS signaling pathways in LO2 cells</article-title>. <source>BMC Complement Altern Med</source>. <year>2019</year>;<volume>19</volume>(<issue>1</issue>):<fpage>255</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12906-019-2671-9</pub-id><pub-id pub-id-type="pmid">31519174</pub-id><pub-id pub-id-type="pmcid">PMC6743105</pub-id></mixed-citation></ref><ref id="ame270055-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="ame270055-cit-0041"><string-name name-style="western"><surname>Leng</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Tian</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Neuroprotective effect of diosgenin in a mouse model of diabetic peripheral neuropathy involves the Nrf2/HO&#8208;1 pathway</article-title>. <source>BMC Compl Med Ther</source>. <year>2020</year>;<volume>20</volume>(<issue>1</issue>):<fpage>126</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12906-020-02930-7</pub-id><pub-id pub-id-type="pmcid">PMC7184706</pub-id><pub-id pub-id-type="pmid">32336289</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>